Literature DB >> 19444722

Supervised methadone consumption: client issues and stigma.

Susan Anstice1, Carol J Strike, Bruna Brands.   

Abstract

Supervised methadone consumption is an important part of methadone maintenance treatment (MMT) but may contribute to stigma for clients. Data from qualitative interviews with MMT clients (n = 64) conducted in 2002-2003 in Canada were analyzed using thematic analytic methods. Three themes dominated clients' accounts of supervised consumption (convenient access to services, relationships with pharmacists and dispensing staff, and attributes of the dispensing space) and were interwoven with experiences of stigmatization. While some dispensing contexts may help clients manage a stigmatized identity, others confer or make visible this identity. Reducing stigmatizing experiences within dispensing environments may improve MMT outcomes and decrease barriers to treatment. The study's limitations are noted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444722     DOI: 10.1080/10826080802483936

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  30 in total

1.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

2.  Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.

Authors:  Lindsay Fox; Lewis S Nelson
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

3.  Negotiating the Relationship Between Addiction, Ethics, and Brain Science.

Authors:  Daniel Z Buchman; Wayne Skinner; Judy Illes
Journal:  AJOB Neurosci       Date:  2010-01

4.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

Review 5.  Global opioid agonist treatment: a review of clinical practices by country.

Authors:  Harry Jin; Brandon D L Marshall; Louisa Degenhardt; John Strang; Matt Hickman; David A Fiellin; Robert Ali; Julie Bruneau; Sarah Larney
Journal:  Addiction       Date:  2020-05-19       Impact factor: 6.526

6.  Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).

Authors:  Laramie R Smith; Maria Luisa Mittal; Karla Wagner; Michael M Copenhaver; Chinazo O Cunningham; Valerie A Earnshaw
Journal:  Addiction       Date:  2019-11-27       Impact factor: 6.526

7.  Drug Addiction Stigma in the Context of Methadone Maintenance Therapy: An Investigation into Understudied Sources of Stigma.

Authors:  Valerie Earnshaw; Laramie Smith; Michael Copenhaver
Journal:  Int J Ment Health Addict       Date:  2013-02-01       Impact factor: 3.836

Review 8.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

9.  The Harnessing Online Peer Education (HOPE) Intervention for Reducing Prescription Drug Abuse: A Qualitative Study.

Authors:  Sean D Young; Keith Heinzerling
Journal:  J Subst Use       Date:  2017-01-31

10.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.